Quantifying secondary pharmacology antagonistic drug effects on platelet function
The development of new drugs is often limited or even halted by their side effects on platelet function. In drug discovery, identifying compounds that might have secondary pharmacological effects on platelet function can contribute to de-risking and help with the progression of potential new drugs. Half-maximal inhibitory concentration (IC50 or pIC50 (-log10IC50)), the concentration of […]
